comparemela.com

Latest Breaking News On - Ridgeback biotherapeutic - Page 3 : comparemela.com

Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai s next Alzheimer s prospect

Eli Lilly penned a $258 million R&D pact with Abbisko Therapeutics. Daiichi Sankyo sold U.S. cardiovascular drugs to Cosette Pharma. Eisai's neurology chief talked about its Aduhelm follow-on drug. And more.

These Are the Latest COVID Treatments

vimarsana © 2020. All Rights Reserved.